DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $705,000 | +25.7% | 3,272 | +3.2% | 0.08% | +23.0% |
| Q2 2020 | $561,000 | +47.2% | 3,172 | +15.3% | 0.06% | +15.1% |
| Q1 2020 | $381,000 | -4.5% | 2,752 | +5.8% | 0.05% | +10.4% |
| Q4 2019 | $399,000 | -10.9% | 2,601 | -16.1% | 0.05% | -20.0% |
| Q3 2019 | $448,000 | +7.2% | 3,100 | +5.9% | 0.06% | +53.8% |
| Q2 2019 | $418,000 | +13.9% | 2,927 | +5.2% | 0.04% | +8.3% |
| Q1 2019 | $367,000 | +31.5% | 2,783 | +2.9% | 0.04% | -28.0% |
| Q4 2018 | $279,000 | -3.1% | 2,704 | +1.8% | 0.05% | -73.3% |
| Q3 2018 | $288,000 | +17.1% | 2,655 | +6.6% | 0.19% | +11.3% |
| Q2 2018 | $246,000 | +6.5% | 2,491 | +5.5% | 0.17% | +7.0% |
| Q1 2018 | $231,000 | +22.2% | 2,361 | +15.7% | 0.16% | +25.6% |
| Q4 2017 | $189,000 | +8.0% | 2,041 | 0.0% | 0.12% | +4.2% |
| Q3 2017 | $175,000 | -1.7% | 2,041 | -3.3% | 0.12% | +20.0% |
| Q2 2017 | $178,000 | +60.4% | 2,111 | +62.0% | 0.10% | +63.9% |
| Q1 2017 | $111,000 | +9.9% | 1,303 | 0.0% | 0.06% | -28.2% |
| Q4 2016 | $101,000 | +38.4% | 1,303 | +40.4% | 0.08% | +37.1% |
| Q3 2016 | $73,000 | +217.4% | 928 | +316.1% | 0.06% | +169.6% |
| Q2 2016 | $23,000 | +4.5% | 223 | -3.9% | 0.02% | 0.0% |
| Q1 2016 | $22,000 | -81.8% | 232 | -82.1% | 0.02% | -82.7% |
| Q4 2015 | $121,000 | -65.4% | 1,298 | -68.4% | 0.13% | -56.8% |
| Q3 2015 | $350,000 | -12.1% | 4,102 | -11.7% | 0.31% | -5.5% |
| Q2 2015 | $398,000 | +0.8% | 4,647 | 0.0% | 0.33% | +6.5% |
| Q1 2015 | $395,000 | -0.8% | 4,647 | 0.0% | 0.31% | +5.2% |
| Q4 2014 | $398,000 | +13166.7% | 4,647 | +11234.1% | 0.29% | +14450.0% |
| Q3 2014 | $3,000 | -25.0% | 41 | -22.6% | 0.00% | -50.0% |
| Q2 2014 | $4,000 | +100.0% | 53 | +60.6% | 0.00% | +100.0% |
| Q1 2014 | $2,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |